Welcome to CDC stacks | Reduced Sensitivity of Influenza A (H5N1) to Oseltamivir - 16722 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Reduced Sensitivity of Influenza A (H5N1) to Oseltamivir
  • Published Date:
    Sep 2007
  • Source:
    Emerg Infect Dis. 13(9):1354-1357.
Filetype[PDF-263.57 KB]


Details:
No Related Documents.
You May Also Like:
  1. I222 Neuraminidase Mutations Further Reduce Oseltamivir Susceptibility of Indonesian Clade 2.1 Highly Pathogenic Avian Influenza A(H5N1) Viruses
    Personal Author:
    McKimm-Breschkin, Jennifer L.; Barrett, Susan; Pudjiatmoko,; Azhar, Muhammad; Wong, Frank Y. K.; Selleck, Paul; Mohr, Peter G.; McGrane, James; Kim, Mia;
    Published:
    Jun 11 2013
    Source:
    PLoS One. 2013; 8(6).
    Description:
    We have tested the susceptibility to neuraminidase inhibitors of 155 clade 2.1 H5N1 viruses from Indonesia, isolated between 2006-2008 as well as 12 clade 1 isolates from Thailand and Cambodia from 2004-2007 using a fluorometric MUNANA-based enzyme i...
    File Type:
    Filetype[PDF - 688.08 KB]
  2. Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Poultry, Vietnam, 2009–2011
    Personal Author:
    Nguyen, Ha T.; Nguyen, Tung; Mishin, Vasiliy P.; Sleeman, Katrina; Balish, Amanda; Jones, Joyce; Creanga, Adrian; Marjuki, Henju; Uyeki, Timothy M.; Nguyen, Dang H.; Nguyen, Diep T.; Do, Hoa T.; Klimov, Alexander I.; Davis, Charles T.; Gubareva, Larisa V.;
    Published:
    Dec 2013
    Source:
    Emerg Infect Dis. 19(12):1963-1971.
    Description:
    We assessed drug susceptibilities of 125 avian influenza A(H5N1) viruses isolated from poultry in Vietnam during 2009-2011. Of 25 clade 1.1 viruses, all possessed a marker of resistance to M2 blockers amantadine and rimantadine; 24 were inhibited by ...
    File Type:
    Filetype[PDF - 635.07 KB]
  3. Mutations I117V and I117M and Oseltamivir Sensitivity of Pandemic (H1N1) 2009 Viruses
    Personal Author:
    Hurt, Aeron C.; Leang, Sook Kwan; Speers, David J.; Barr, Ian G.; Maurer-Stroh, Sebastian;
    Published:
    Jan 2012
    Source:
    Emerg Infect Dis. 18(1):109-112.
    Description:
    Analysis of mutations I117V and I117M in the neuraminidase of influenza A pandemic (H1N1) 2009 viruses showed that I117V confers a mild reduction in oseltamivir sensitivity and has a synergistic effect of further increasing resistance when combined w...
    File Type:
    Filetype[PDF - 313.28 KB]
  4. Cost-effectiveness of Antiviral Stockpiling and Near-Patient Testing for Potential Influenza Pandemic
    Personal Author:
    Siddiqui, M. Ruby; Edmunds, W. John;
    Published:
    Feb 2008
    Source:
    Emerg Infect Dis. 14(2):267-274.
    Description:
    A decision analytical model was developed to investigate the cost-effectiveness of stockpiling antiviral (AV) drugs for a potential influenza pandemic in the United Kingdom and the possible role of near-patient testing in conserving AV drug stocks. U...
    File Type:
    Filetype[PDF - 424.29 KB]
  5. Detection of Pandemic (H1N1) 2009 Virus in Patients Treated with Oseltamivir
    Personal Author:
    Boutolleau, David; Houhou, Nadhira; Deback, Claire; Agut, Henri; Brun-Vézinet, Françoise;
    Published:
    Feb 2010
    Source:
    Emerg Infect Dis. 16(2):351-352.
    File Type:
    Filetype[PDF - 79.97 KB]